Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance.
Clinical Benefit
| Substantial |
The transparency Committee considers that the actual benefit of ARAVA continues to be substantial in the indications in the Marketing Authorisation. |
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
QEbktv5qDDHUNJ4b
Listen
